171 related articles for article (PubMed ID: 22981610)
21. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
[TBL] [Abstract][Full Text] [Related]
22. Prognosis of gastric carcinoma with emphasis on lymph node status.
Topal B; Trimpeneers F; Hendrickx J
Acta Chir Belg; 1997 Jun; 97(3):118-22. PubMed ID: 9224514
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer.
Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Lee JH; Kim YS
J Surg Res; 2010 Aug; 162(2):177-83. PubMed ID: 20031164
[TBL] [Abstract][Full Text] [Related]
24. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
Roukos DH; Lorenz M; Encke A
Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
[TBL] [Abstract][Full Text] [Related]
25. The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients.
Fukagawa T; Sasako M; Shimoda T; Sano T; Katai H; Saka M; Mann GB; Karpeh M; Coit DG; Brennan MF
Ann Surg Oncol; 2009 Mar; 16(3):609-13. PubMed ID: 19137375
[TBL] [Abstract][Full Text] [Related]
26. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes.
Xu DZ; Geng QR; Long ZJ; Zhan YQ; Li W; Zhou ZW; Chen YB; Sun XW; Chen G; Liu Q
Ann Surg Oncol; 2009 Feb; 16(2):319-26. PubMed ID: 19050970
[TBL] [Abstract][Full Text] [Related]
27. The patterns and timing of recurrence after curative resection for gastric cancer in China.
Liu D; Lu M; Li J; Yang Z; Feng Q; Zhou M; Zhang Z; Shen L
World J Surg Oncol; 2016 Dec; 14(1):305. PubMed ID: 27931221
[TBL] [Abstract][Full Text] [Related]
28. Extension of lymph node dissection and survival in primary gastric cancer.
Secco GB; Fardelli R; Campora E; Rovida S; Beatini M; Larghero G; Testa T; Prior C
Int Surg; 1992; 77(4):242-7. PubMed ID: 1478803
[TBL] [Abstract][Full Text] [Related]
29. Indications for pancreaticosplenectomy in advanced gastric cancer.
Chikara K; Hiroshi S; Masato N; Hirotoshi A; Goro M; Hidetaka O
Hepatogastroenterology; 2001; 48(39):908-12. PubMed ID: 11462954
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant chemoradiation versus chemotherapy in completely resected advanced gastric cancer with D2 nodal dissection.
Kwon HC; Kim MC; Kim KH; Jang JS; Oh SY; Kim SH; Kwon KA; Lee S; Lee HS; Kim HJ
Asia Pac J Clin Oncol; 2010 Dec; 6(4):278-85. PubMed ID: 21114777
[TBL] [Abstract][Full Text] [Related]
31. Association of positive transection margins with gastric cancer survival and local recurrence.
Bickenbach KA; Gonen M; Strong V; Brennan MF; Coit DG
Ann Surg Oncol; 2013 Aug; 20(8):2663-8. PubMed ID: 23536054
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of intraoperative chemotherapy and extensive lymphadenectomy in patients with node-negative gastric cancer.
Wang J; Yu JC; Kang WM; Ma ZQ
J Surg Oncol; 2012 Mar; 105(4):400-4. PubMed ID: 22311818
[TBL] [Abstract][Full Text] [Related]
33. Role of surgery in the patients with stage I and II primary gastric lymphoma.
Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
[TBL] [Abstract][Full Text] [Related]
34. Metastasis in para-aortic lymph nodes in patients with advanced gastric cancer, treated with extended lymphadenectomy.
Yonemura Y; Wu CC; Fukushima N; Honda I; Bandou E; Kawamura T; Kamata S; Yamamoto H; Kim BS; Matsuki N; Sawa T; Noh SH;
Hepatogastroenterology; 2007 Mar; 54(74):634-8. PubMed ID: 17523339
[TBL] [Abstract][Full Text] [Related]
35. [The effect of regional lymphatic metastasis on the methods and results of treating stomach neoplasms].
Murawa P; Nowakowski W; Gracz A
Wiad Lek; 1997; 50 Suppl 1 Pt 2():407-10. PubMed ID: 9424912
[TBL] [Abstract][Full Text] [Related]
36. Comparison of staging between the old (6th edition) and new (7th edition) TNM classifications in advanced gastric cancer.
Kikuchi S; Futawatari N; Sakuramoto S; Katada N; Yamashita K; Shibata T; Nemoto M; Watanabe M
Anticancer Res; 2011 Jun; 31(6):2361-5. PubMed ID: 21737665
[TBL] [Abstract][Full Text] [Related]
37. Prophylactic lymph node dissection for early gastric cancer invading submucosa.
Ikeda Y; Saku M; Kawanaka H; Nonaka M; Yoshida K; Maehara Y; Sugimachi K
Hepatogastroenterology; 2004; 51(57):887-90. PubMed ID: 15143940
[TBL] [Abstract][Full Text] [Related]
38. The prognostic analysis of lymph node-positive gastric cancer patients following curative resection.
Deng J; Liang H; Sun D; Pan Y
J Surg Res; 2010 Jun; 161(1):47-53. PubMed ID: 19783008
[TBL] [Abstract][Full Text] [Related]
39. Prognosis of curatively resected pT4b gastric cancer with respect to invaded organ type.
Min JS; Jin SH; Park S; Kim SB; Bang HY; Lee JI
Ann Surg Oncol; 2012 Feb; 19(2):494-501. PubMed ID: 21837527
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological characteristics and outcome indicators of stage II gastric cancer according to the Japanese classification of gastric cancer.
Ojima H; Araki K; Kato T; Okamura K; Manda R; Hirayama I; Hosouchi Y; Nishida Y; Kuwano H
Anticancer Res; 2006; 26(2B):1385-90. PubMed ID: 16619548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
